929911-61-5

Basic information

• Product Name: (3-hydroxycyclobutyl)methyl benzoate
• Synonyms: (3-hydroxycyclobutyl)methyl benzoate
• CAS NO: 929911-61-5
• Molecular Weight: 206.241
• Mol File: 929911-61-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3-hydroxycyclobutyl)methyl benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: (3-hydroxycyclobutyl)methyl benzoate(929911-61-5)
• EPA Substance Registry System: (3-hydroxycyclobutyl)methyl benzoate(929911-61-5)

Safety Data

• Hazardous Substances Data: 929911-61-5(Hazardous Substances Data)

Upstream product

• 98-88-4 benzoyl chloride 
• 23761-23-1 3-oxocyclobutanecarboxylic acid 
• 346425-59-0 (3-oxo-cyclobutyl)methyl benzoate 
• 175021-11-1 (3,3-bis-methoxy-cyclobutyl)methanol 
• 98231-07-3 3,3-dimethoxycyclobutanecarboxylic acid methyl ester 
• 695-95-4 methyl 3-oxocyclobutanecarboxylate 

Downstream Products

• 929911-63-7 ((3-((methylsulfonyl)oxy)cyclobutyl)methyl)benzoate 

Relevant articles and documents

Containing cyclobutane substituent of pyrazines, its composition and use thereof

The invention relates to a cyclobutane substituent group-containing pyrazine compound and application thereof as a drug, and particularly relates to application of the cyclobutane substituent group-containing pyrazine compound in preparing the drug for preventing and treating various influenza viruses. Especially, the invention relates to a compound as shown in a general formula (I) or a stereomer, a geometrical isomer, a tautomer, a nitrogen oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and various variables are defined in the specification. The invention also relates to application of the compound as shown in the general formula (I) or the stereomer, geometrical isomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug thereof as the drug, and particularly relates to application of the compound as shown in the general formula (I) or the stereomer, geometrical isomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug thereof as the drug for preventing and treating the influenza viruses.